PuSH - Publikationsserver des Helmholtz Zentrums München

50 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
21.
Zhang, D.* et al.: Viral integration profiles in the plasma cell-free DNA from patients with HBV infection well represent tumor clone compositions during HCC development. J. Hepatol. 68, S121-S122 (2018)
22.
Michler, T. et al.: Preclinical study of a combinatorial RNAi/vaccination therapy as a potential cure for chronic hepatitis B. J. Hepatol. 66, S112-S112 (2017)
23.
Protzer, U.: Visualizing HEV infection in human liver tissue. J. Hepatol. 67, 471–479 (2017)
24.
Wisskirchen, K. et al.: Hepatitis B virus-specific T cell receptors with high functional avidity redirect T cells to eliminate HBV. J. Hepatol. 66, S29-S30 (2017)
25.
Xia, Y. et al.: Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions. J. Hepatol. 66, 494-503 (2017)
26.
Blondot, M.L.* ; Bruss, V. & Kann, M.*: Intracellular transport and egress of hepatitis B virus. J. Hepatol. 64, S49-S59 (2016)
27.
Bohne, F. et al.: BI-and trispecific antibodyconstructs mediate specific TCell retargeting towards and elimination of HBV-positive hepatocytes and tumor cells. J. Hepatol. 64, S387-S387 (2016)
28.
Einer, C. et al.: Mitochondrial adaptation to high caloric challenge protects against fatty acid-induced hepatotoxicity but promotes liver steatosis in nash. J. Hepatol. 64, S684-S684 (2016)
29.
Hohenester, S.* et al.: Progression of non-alcoholic fatty liver disease towards steatohepatitis is differentially mediated by inflammasome-induced downstream pathways IL-1 and IL-18. J. Hepatol. 64, S683-S684 (2016)
30.
Karimzadeh, H. et al.: Correlation of mutations within HDV-protein with HLA Backgrounds of patients leads to identification of novel CD8 T cell epitopes. J. Hepatol. 64, S361-S361 (2016)
31.
Koppe, C.* et al.: Ikkalpha/beta regulate hepatocarcinogenesis and biliary homeostasis by controlling RIPK1 activity. J. Hepatol. 64, S312-S313 (2016)
32.
Kremer, L.S. et al.: Severe respiratory complex III defect prevents liver adaptation to prolonged fasting. J. Hepatol. 65, 377-385 (2016)
33.
Lucifora, J.* & Protzer, U.: Attacking hepatitis B virus cccDNA - the holy grail to hepatitis B cure. J. Hepatol. 64, S41-S48 (2016)
34.
Michler, T. et al.: RNA interference mediated suppression of HBV transcripts restores HBV-specific immunity and enhances the efficacy of therapeutic vaccination. J. Hepatol. 64, S148-S149 (2016)
35.
Sauer, V.* et al.: Analysis of treatments for wilson disease using patient-specific induced pluripotent stem (IPS) cells derived from urine. J. Hepatol. 64, S305-S305 (2016)
36.
Xia, Y.* ; Carpentier, A.* ; Zhang, Z.* ; Protzer, U. & Liang, T.J.*: Hepatitis B virus infection of human stem cells-derived hepatocyte-like cells. J. Hepatol. 64, S398-S398 (2016)
37.
Bohne, F. et al.: Bispecific antibody constructs mediate specific retargeting towards and elimination of hbv-positive hepatocytes and tumor cells. J. Hepatol. 62, S555-S556 (2015)
38.
Michler, T.* et al.: RNAi-based gene therapy for chronic hepatitis B: Evaluation in a murine model. L. J. Hepatol. 62, S526 (2015)
39.
Sprinzl, M.F. et al.: Sorafenib inhibits macrophage-induced growth of hepatoma cells by interference with insulin-like growth factor-1 secretion. J. Hepatol. 62, 863-870 (2015)
40.
Eichenmüller, M.* et al.: The genomic landscape of hepatoblastoma and their progenies with HCC-like features. J. Hepatol. 61, 1312-1320 (2014)